Similar to the HEAL trial, the PAEAN trial in @jamapediatrics.com found no difference in EPO + TH vs TH alone in the reduction of death or disability in newborns with HIE. jamanetwork.com/journals/jamap… #EBNEOalerts #neoEBM #neoSky

Kakkilaya et al. conducted a multicenter pilot randomized clinical trial comparing Delivery Room Less-Invasive Surfactant Administration (DR-LISA) with Early Rescue NICU-LISA in extremely preterm infants (22–25 weeks GA). buff.ly/XLvXdbf #EBNeoAlerts #NeoEBM #NeoSky

Early registration for #CEPAS2026 ends July 31st! Register now for the best rates for members and non-members. buff.ly/Hyw10SS Join @ebneo.bsky.social in Lyon, France from 28-31 October 2026 to see cutting edge neonatal science. #neosky #neoEBM @espr-esn.bsky.social

Faust et al. conducted a cluster-randomized crossover trial comparing Standard Hand Hygiene with Extended Barrier Precautions in NICU infants colonized with third-generation cephalosporins–resistant GN bacteria (3GCR-GNB). buff.ly/blxB0kw #EBNeoAlerts #NeoEBM #NeoSky @jamanetworkopen.com

Nangia et al. conducted an open-label RCT comparing Early Total Enteral Feeding (ETEF) with Conventional Enteral Feeding (CEF) in preterm neonates (27–32 weeks) buff.ly/Kf4aOss #EBNeoAlerts #NeoEBM #neosky

A longitudinal cohort study in @jamapediatrics.com of 7,000+ preterm infants reveals inequities in referrals, evaluations, etc., in the Early Intervention cascade. #ebneoalerts #equity4babies #EBNEOEquityAlerts #neoSky #neoEBM jamanetwork.com/journals/jam...

Deadline is today! Submit your late-breaking abstracts and join us at #CEPAS2026 Lyon, France - October 28-31 buff.ly/iGwgepY @espr-esn.bsky.social #neoSky #neoEBM

There are only 2 days left to submit your late-breaking abstract for CEPAS 2026. Don’t miss your chance to present your research at the new meeting of the European Academy of Paediatrics & ESPR, in collab. with GFCNI, @99nicu.bsky.social & @ebneo.bsky.social in Lyon, 28-31 October! www.cepas.org

5 year follow-up from the PROVIDE trial suggests that additional parenteral AA (1 g/d for 5 days) in ELBW infants does not improve school-age neurocognitive outcomes, and may have potential adverse effects on muscle strength and psychosocial function: buff.ly/cwQ0idh #EBNEOalerts #neoEBM #neosky

3-year interim analysis of the FIREFLEYE next trial demonstrates that aflibercept provides stable control for ROP and comparable safety to laser therapy buff.ly/syYWEED #EBNEOalerts #neoEBM #neosky

Even without bradycardia, oxygen desaturations in very preterm infants are linked to significant cerebral and abdominal hypoxemia. karger.com/neo/article/12… #EBNEOalerts #neoEBM #neosky

Mitra et al. conducted a comparative effectiveness research study to compare the relative effectiveness of different PDA regimens and to compare the clinical outcomes between infants treated with pharmacotherapy and those not treated. buff.ly/JEZiU5U #EBNeoAlerts #NeoEBM #neosky

Martinez et al. conducted a post-hoc exploratory analysis of PLUSS to describe the early respiratory trajectories of infants born <26 weeks’ gestation who received surfactant during their initial NICU admission. buff.ly/Hk697aO #EBNeoAlerts #NeoEBM #neosky

Siefkes et al Vs Mitra et al Which publication posted by @ebneo.bsky.social during May is most likely to impact your practice? IAOTM Vote is now open on our website! ebneo.org/vote #EBNeoPolls #neoSky #neoEBM

Could dexamethasone drops prevent progression of ROP? Swedish population cohort study explores this: aaojournal.org/article/S0161-… #neoEBM #EBNEOalerts #neosky

Start reviewing the programme and planning your trip. Don't miss the cutting edge science! #neoEBM #neosky

European Society for Paediatric Research (ESPR)@espr-esn.bsky.social · 3mo ago

The interactive scientific programme of our 2026 international meeting @cepascongress.bsky.social together with EAP & in collab. with GFCNI is live. Explore session details, confirmed talks & speakers! Kindly supported by @99nicu.bsky.social & @ebneo.bsky.social. More: www.cepas.org/scientific-p...

The @ebneo.bsky.social 2025 Impact Article of the Year race is down to the final two! After a high-stakes first round, these 2 RCTs have emerged as the frontrunners: Faix et al. Laughon et al. Vote now to crown the winner! 🗳️ ⏳ Open for 5 days only! buff.ly/XvU87C4 #neosky #neoEBM

‼️ Abstract Deadline Extended‼️ Think you missed the deadline yesterday? Don't fret! New deadline April 15th! Get your abstracts submitted and join @EBNEO in Lyon, France for #CEPAS2026 in October. Submit now: buff.ly/ANz6BNi #neosky #neoEBM @espr-esn.bsky.social

Which research shaped neonatology in 2025? 🚀 The EBNEO Impact Article of the Year finalists are live! Help us narrow 8 candidates down to the top 2. Voting is open for 7 days. Make your choice on our website: ebneo.org/impact #neosky #neoEBM #IAOTY #EBNEOpolls

Delighted & honoured to be contributing to the iconic “Cool Topics in Neonatology 2025” at The Women’s Melbourne with great friends & colleagues! @ebneo.bsky.social @drbretty.bsky.social @nnrdbase.bsky.social @europerinatal.bsky.social www.thewomens.org.au/health-profe...

Results of the MoCHA Trial, an NIH NRN funded trial led by Dr. Carlo, published in @jama.com. Does continuing caffeine past discharge in moderately preterm infants shorten length of stay? buff.ly/TrA3w3c #neotwitter #neoEBM #EBNEOalerts

A multicentre randomized non-inferiority trial compares 7 day and 14 day antibiotic courses for uncomplicated neonatal bacterial sepsis in 8 centres in India. buff.ly/dm7j9Hz #neotwitter #neoEBM #EBNEOalerts

David Rub & Elizabeth Foglia review Gallini et al's 2y FU of IN-REC-SURE trial READ:buff.ly/XRPm74P Acta Paediatrica: buff.ly/GelMxpV Incubator: buff.ly/ddRnjpa @99nicu.bsky.social: buff.ly/0M84w72 #neotwitter #EBNEOreviews #ebneoAOM @jama.com

Drs Spahic, Zoubovsky, & Dietz review Faix et al's RCT on TH in neonatal encephalopathy in 33-35 GA READ: buff.ly/ujavt3Z Acta Paediatrica: buff.ly/BGvUgez 99nicu: buff.ly/FTcj81u #neotwitter #EBNEOreviews #ebneoAOM @jama.com

Excited to be at #PAS2025 🌺 ! Join me at the following sessions: - Workshop on Research Integrity @ebneo.bsky.social - Oral abstract session on Neonatal Neuroscience - Hot Topic Symposium on Regenerative Cell Therapies

Double-blind, parallel-group randomized trial to assess the effect of norepinephrine vs dopamine as first-line vasoactive agent in neonates with fluid refractory septic shock. #neobluesky #EBNeo #neoEBM #ebneoalerts buff.ly/fZdDFF6

A prospective cohort study enrolling from August 2020 to December 2023 to compare global, regional, and tissue-specific brain volumes in opioid-exposed newborns vs unexposed controls. @jama.com #neobluesky #neoEBM #ebneoalerts

A retrospective study using PRAMS data examines disparities by gestational age in the provision of mother's own milk (MOM) @JAMANetworkOpen buff.ly/YeCPlqH #ebneoalerts #equity4babies #EBNEOEquityAlerts #neobluesky #neoEBM

In this secondary analyses of the ETTNO trial, Franz et al compared the effect of liberal versus restrictive transfusion strategies on intermittent hypoxaemia in ELBW infants. buff.ly/33uSCbK #EBNeoAlerts #NeoEBM #neobluesky

In this randomized controlled trial, DeMauro et al. compared oximetry and clinical outcomes in infants with established BPD who were randomized to higher (≥96%) or lower (90–94%) oxygen saturation target ranges. buff.ly/Lf9KW9N #EBNeoAlerts #NeoEBM #neobluesky